初次住院后COVID-19状态患者的脑18F-FDG-PET异常及其与神经心理评估的关联:一项前瞻性纵向研究
该前瞻性纵向研究纳入23例初次住院且确认神经功能受损的后COVID-19状态(PCC)患者,在入组时和一年后分别进行脑18F-FDG-PET与神经心理评估(NPA)。脑代谢与汉密尔顿焦虑量表(HARS)、情景记忆、执行功能和自主性测试相关,入组时及一年后均发现小脑低代谢簇,一年后小脑代谢与异常HARS相关,但脑代谢和NPA均未见显著改善。
要点
- 23例PCC患者在入组时和一年后接受脑18F-FDG-PET与NPA,脑代谢与HARS、情景记忆、执行功能和自主性测试相关。
- 入组时及一年后均发现两个小脑低代谢簇(n=16)。
- 一年后小脑代谢与异常HARS相关,但脑代谢和NPA未见显著改善。
核心结论
- 脑18F-FDG-PET代谢与初次住院PCC患者的神经心理测试结果相关,尤其是小脑代谢降低与患者焦虑症状相关。
- 脑18F-FDG-PET低代谢和NPA测试损害在一年后未显著改善。
研究设计与样本
- 前瞻性纵向研究,纳入23例初次住院且确认神经功能受损的PCC患者(51.0 ± 9.5岁;9名女性)。
- 患者在入组时和一年后均接受脑18F-FDG-PET和NPA,脑代谢与NPA测试进行相关分析。
主要发现
- 脑18F-FDG-PET代谢与HARS、情景记忆、执行功能和自主性测试结果相关(p-voxel < 0.005;p-cluster < 0.05未校正)。
- 入组时和一年后均发现两个小脑低代谢簇(n = 16,p-voxel < 0.005;p-cluster < 0.05校正)。
- 一年时小脑代谢与异常HARS测试相关(p ≤ 0.04),但入组时无此关联。
- 一年后未观察到脑代谢恢复,NPA测试也无显著改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: This study aims to longitudinally investigate the associations between brain 18F-FDG-PET metabolism and neuropsychological assessment (NPA) in initially hospitalized patients with post-COVID-19 conditions (PCCs). METHODS: Patients with PCC and confirmed neurological impairment were prospectively included and underwent both brain 18F-FDG-PET and NPA at inclusion and one year later. Brain18F-FDG-PET metabolism was correlated with NPA tests. The identified hypometabolic clusters after quantitative voxel-by-voxel group analyses were correlated with the NPA results. RESULTS: Twenty-three patients (51.0 ± 9.5 years; 9 women) were included. Brain 18F-FDG-PET metabolism was correlated with the results of the Hamilton Anxiety Rating Scale (HARS), episodic memory, executive function and autonomy tests (p-voxel < 0.005; p-cluster < 0.05 uncorrected). Two cerebellar hypometabolic clusters were found in patients with PCC at inclusion and one year later (n = 16, p-voxel < 0.005; p-cluster < 0.05 corrected). Cerebellar metabolism was associated with an abnormal HARS test at one year (p ≤ 0.04) but not at inclusion. At one year, no brain metabolic recovery and no significant improvement in NPA tests were observed. CONCLUSION: Brain 18F-FDG-PET metabolism is associated with the results of neuropsychological tests in initially hospitalized patients with PCC, especially the metabolism of the cerebellum, which was found to be decreased in patients, and symptoms of anxiety experienced by patients. Similarly, brain 18F-FDG-PET hypometabolism and impairment in NPA tests did not significantly improve one year later.
引用
- Heyer S, Meyer M, Hossu G, et al. Brain 18F-FDG-PET abnormalities and their associations with neuropsychological assessment in initially hospitalized patients with post-COVID-19 conditions: a prospective and longitudinal study. Eur J Nucl Med Mol Imaging. 2025. PMID: 40137975. doi:10.1007/s00259-025-07204-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。